| |
| Device | Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System |
| Generic Name | Absorbable coronary drug-eluting stent |
| Applicant | Abbott Vascular, Inc. 3200 Lakeside Dr. Santa Clara, CA 95054 |
| PMA Number | P150023 |
| Supplement Number | S010 |
| Date Received | 03/01/2018 |
| Decision Date | 05/30/2018 |
| Withdrawal Date | 05/11/2023 |
| Product Code |
PNY |
| Advisory Committee |
Cardiovascular |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for implementation of everolimus BHT manufactured at a new manufacturing site. |